Prolymphocytic Leukemia, also known as prolymphocytic leukaemia, is related to b-cell prolymphocytic leukemia and t-cell prolymphocytic leukemia. An important gene associated with Prolymphocytic Leukemia is MTCP1 (Mature T Cell Proliferation 1), and among its related pathways/superpathways are PI3K-Akt signaling pathway and Nuclear receptors meta-pathway. The drugs Auranofin and Ofatumumab have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and spleen, and related phenotypes are endocrine/exocrine gland and immune system